170 related articles for article (PubMed ID: 15073669)
21. Detailed analysis of mucosal herpes simplex virus-2 replication kinetics with and without antiviral therapy.
Schiffer JT; Magaret A; Selke S; Corey L; Wald A
J Antimicrob Chemother; 2011 Nov; 66(11):2593-600. PubMed ID: 21865349
[TBL] [Abstract][Full Text] [Related]
22. Single-dose, patient-initiated famciclovir: a randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialis.
Spruance SL; Bodsworth N; Resnick H; Conant M; Oeuvray C; Gao J; Hamed K
J Am Acad Dermatol; 2006 Jul; 55(1):47-53. PubMed ID: 16781291
[TBL] [Abstract][Full Text] [Related]
23. Current recommendations for the treatment of genital herpes.
Leung DT; Sacks SL
Drugs; 2000 Dec; 60(6):1329-52. PubMed ID: 11152015
[TBL] [Abstract][Full Text] [Related]
24. Single-day famciclovir for the treatment of genital herpes: follow-up results of time to next recurrence and assessment of antiviral resistance.
Bodsworth N; Fife K; Koltun W; Tyring S; Abudalu M; Prichard M; Hamed K
Curr Med Res Opin; 2009 Feb; 25(2):483-7. PubMed ID: 19192993
[TBL] [Abstract][Full Text] [Related]
25. Single-day famciclovir therapy for recurrent genital herpes.
Whitley R; Diaz-Mitoma F; Hamed K
Curr Med Res Opin; 2006 Jul; 22(7):1307-10. PubMed ID: 16834829
[TBL] [Abstract][Full Text] [Related]
26. Oral famciclovir for recurrent genital herpes.
Brown D
J Fam Pract; 1996 Oct; 43(4):341-2. PubMed ID: 8926485
[No Abstract] [Full Text] [Related]
27. Famciclovir for cutaneous herpesvirus infections: an update and review of new single-day dosing indications.
Chacko M; Weinberg JM
Cutis; 2007 Jul; 80(1):77-81. PubMed ID: 17725069
[TBL] [Abstract][Full Text] [Related]
28. Famciclovir: review of clinical efficacy and safety.
Cirelli R; Herne K; McCrary M; Lee P; Tyring SK
Antiviral Res; 1996 Mar; 29(2-3):141-51. PubMed ID: 8739594
[TBL] [Abstract][Full Text] [Related]
29. Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster.
Shen MC; Lin HH; Lee SS; Chen YS; Chiang PC; Liu YC
J Microbiol Immunol Infect; 2004 Apr; 37(2):75-81. PubMed ID: 15181487
[TBL] [Abstract][Full Text] [Related]
30. Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes.
Simpson D; Lyseng-Williamson KA
Drugs; 2006; 66(18):2397-416. PubMed ID: 17181386
[TBL] [Abstract][Full Text] [Related]
31. Peroral famciclovir in the treatment of experimental ultraviolet radiation-induced herpes simplex labialis: A double-blind, dose-ranging, placebo-controlled, multicenter trial.
Spruance SL; Rowe NH; Raborn GW; Thibodeau EA; D'Ambrosio JA; Bernstein DI
J Infect Dis; 1999 Feb; 179(2):303-10. PubMed ID: 9878012
[TBL] [Abstract][Full Text] [Related]
32. A meta-analysis to assess the efficacy of oral antiviral treatment to prevent genital herpes outbreaks.
Lebrun-Vignes B; Bouzamondo A; Dupuy A; Guillaume JC; Lechat P; Chosidow O
J Am Acad Dermatol; 2007 Aug; 57(2):238-46. PubMed ID: 17416440
[TBL] [Abstract][Full Text] [Related]
33. Advances in the treatment of herpesvirus infection: the role of famciclovir.
Tyring SK
Clin Ther; 1998; 20(4):661-70. PubMed ID: 9737826
[TBL] [Abstract][Full Text] [Related]
34. The continuing evolution of antiviral therapy for recurrent genital herpes: 1-day patient-initiated treatment with famciclovir.
Aoki FY
Herpes; 2007 Dec; 14(3):62-5. PubMed ID: 18371288
[TBL] [Abstract][Full Text] [Related]
35. Rapid viral expansion and short drug half-life explain the incomplete effectiveness of current herpes simplex virus 2-directed antiviral agents.
Schiffer JT; Swan DA; Corey L; Wald A
Antimicrob Agents Chemother; 2013 Dec; 57(12):5820-9. PubMed ID: 24018260
[TBL] [Abstract][Full Text] [Related]
36. A review of famciclovir in the management of genital herpes.
Faro S
Infect Dis Obstet Gynecol; 1998; 6(1):38-43. PubMed ID: 9678146
[TBL] [Abstract][Full Text] [Related]
37. Single-day therapy: an expert opinion on a recent development for the episodic treatment of recurrent genital herpes.
Tyring S; Richwald G; Hamed K
Arch Gynecol Obstet; 2007 Jan; 275(1):1-3. PubMed ID: 16957911
[TBL] [Abstract][Full Text] [Related]
38. Famciclovir for the treatment of recurrent genital and labial herpes lesions.
Langley RG
Skin Therapy Lett; 2005 Dec-2006 Jan; 10(10):5-7. PubMed ID: 16408140
[TBL] [Abstract][Full Text] [Related]
39. A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection.
Brocklehurst P; Kinghorn G; Carney O; Helsen K; Ross E; Ellis E; Shen R; Cowan F; Mindel A
Br J Obstet Gynaecol; 1998 Mar; 105(3):275-80. PubMed ID: 9532986
[TBL] [Abstract][Full Text] [Related]
40. Progress in meeting today's demands in genital herpes: an overview of current management.
Patel R
J Infect Dis; 2002 Oct; 186 Suppl 1():S47-56. PubMed ID: 12353187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
